Test propionate dose

In rare cases, patients on inhaled fluticasone propionate may present with systemic eosinophilic conditions. Some of these patients have clinical features of vasculitis consistent with Churg-Strauss syndrome , a condition that is often treated with systemic corticosteroid therapy. These events usually, but not always, have been associated with the reduction and/or withdrawal of oral corticosteroid therapy following the introduction of fluticasone propionate. Cases of serious eosinophilic conditions have also been reported with other inhaled corticosteroids in this clinical setting. Physicians should be alert to eosinophilia , vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal relationship between fluticasone propionate and these underlying conditions has not been established.

ALABAMA - ALASKA - ARIZONA - ARKANSAS - CALIFORNIA - COLORADO - CONNECTICUT - DELAWARE - FLORIDA - GEORGIA - HAWAII - IDAHO - ILLINOIS - INDIANA - IOWA - KANSAS - KENTUCKY - LOUISIANA - MAINE - MARYLAND - MASSACHUSETTS - MICHIGAN - MINNESOTA - MISSISSIPPI - MONTANA - NEBRASKA - NEW HAMPSHIRE - NEW YORK - NEW JERSEY - NEW MEXICO - NEVADA - NORTH CAROLINA - NORTH DAKOTA - OHIO - OKLAHOMA - OREGON - PENNSYLVANIA - RHODE ISLAND - SOUTH CAROLINA - SOUTH DAKOTA - TENNESSEE - TEXAS - UTAH - VERMONT - VIRGINIA - WASHINGTON - WASHINGTON DC - WEST VIRGINIA - WISCONSIN - WYOMING

Important Safety Information for VECTICAL ® (calcitriol) Ointment

Indication: VECTICAL ® Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse reactions (≥ 3%) were lab test abnormality, urine abnormality, psoriasis, hypercalciuria, pruritus, and skin discomfort. Warnings/Precautions: The maximum weekly dose should not exceed 200 g. Avoid contact with eyes, lips and face. VECTICAL ® Ointment should be used with caution in patients receiving medications known to increase the serum calcium level, such as thiazide diuretics and in patients receiving calcium supplements or high doses of Vitamin D. If aberrations in parameters of calcium metabolism are noted discontinue VECTICAL ® Ointment until these normalize. Avoid excessive exposure of VECTICAL ® Ointment treated areas to either natural or artificial sunlight.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit /medwatch or call 1-800-FDA-1088 (1-800-332-1088).

Click here for Full Prescribing Information for VECTICAL ® Ointment

Test propionate dose

test propionate dose

Media:

test propionate dosetest propionate dosetest propionate dosetest propionate dosetest propionate dose